Back

Evolution of cardiovascular risk factors, analytical markers and functional capacity. Are the benefits of phase II of the cardiac rehabilitation program maintained in phase III?

12 April 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Risk Factors and Prevention - Secondary Prevention Secondary Prevention EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Mrs Belen Garcia Magallon

Guadalajara University Hospital, Guadalajara (Spain)

30 More presentations in this session

Presentation thumbnail
Doctor J. Kim (Seoul, KR)
Abstract
Presentation thumbnail
Doctor T. Terada (Nottingham, GB)
Abstract
Presentation thumbnail
Doctor R. Reid (Ottawa, CA)
Abstract Slides
Presentation thumbnail
Miss P. Jepma (Amsterdam, NL)
Abstract
Presentation thumbnail
Doctor J. Coelho Lima Junior (Cambridge, GB)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Risk Factors and Prevention - Secondary Prevention

The Event

Event poster

EuroPrevent 2019

12 April 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Changes in cardiorespiratory fitness following phase iii cardiac rehabilitation: findings from a 12-month follow-up
4 April 2025
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024
thumbnail
Congress Presentation
ACS Program. Improving secondary prevention in patients admitted due to a myocardial infarction. First year experience
25 April 2024
thumbnail
Congress Presentation
Effect of a physical activity program and nutritional treatment on cardiovascular risk and functional capacity
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources